Anzeige
Mehr »
Login
Freitag, 16.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Codename: Siebzehntausend! Rritual landet den "Super-Vertrag"!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AT0Z ISIN: CH0334081137 Ticker-Symbol: 1CG 
Lang & Schwarz
16.04.21
07:00 Uhr
103,50 Euro
0,00
0,00 %
1-Jahres-Chart
CRISPR THERAPEUTICS AG Chart 1 Jahr
5-Tage-Chart
CRISPR THERAPEUTICS AG 5-Tage-Chart
RealtimeGeldBriefZeit
102,00105,0007:00

Aktuelle News zur CRISPR THERAPEUTICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoCRISPR Therapeutics AG (CRSP) Presents at 20th Annual Needham Virtual Healthcare Conference (Transcript)19
CRISPR THERAPEUTICS Aktie jetzt für 0€ handeln
SaCRISPR Therapeutics AG: CRISPR Therapeutics Presents Preclinical Data at AACR 2021 Supporting CD70 Knockout as a Novel Approach to Increasing CAR-T Cell ...26
08.04.CRISPR Therapeutics (CRSP) Investor Presentation - Slideshow16
06.04.Is CRSP Stock A Buy or Sell?60
06.04.CRISPR Therapeutics's Leading Thalassemia And Sickle Cell Disease Investigational Therapy12
01.04.Crispr Therapeutics Stock Sees Improved Relative Strength Rating35
26.03.Hedge Fund and Insider Trading News: Ray Dalio, Warren Buffett, Soros Fund Management, Lansdowne Partners, Altus Strategies PLC (ALTUF), Crispr Therapeutics AG (CRSP), and More49
17.03.Is CRISPR Therapeutics Stock Poised to Soar Nearly 30%?93
16.03.CRISPR Therapeutics Stock Looks Like a Long-Term Biotech Winner42
15.03.CRISPR Therapeutics AG's (CRSP) CEO Samarth Kulkarni Presents At 33rd Annual ROTH Conference (Transcript)15
15.03.CRISPR Therapeutics (CRSP) Investor Presentation - Slideshow10
11.03.CRISPR Therapeutics Is a Falling Knife You Don't Want to Catch60
10.03.CRISPR Therapeutics AG: CRISPR Therapeutics Announces Poster Presentation at the American Association for Cancer Research 2021 Annual Meeting16
10.03.Gene Editing Stocks: What BLUE, NTLA, BEAM, CRSP and EDIT Are Doing Today11
09.03.Crispr Therapeutics AG's (CRSP) CEO Samarth Kulkarni Presents at Barclays Global Healthcare Conference 2017 (Transcript)15
09.03.Why CRSP Stock Is a Less Dicey Risk Asset Today17
03.03.CRISPR Therapeutics AG: CRISPR Therapeutics to Participate in Upcoming Investor Conferences60
02.03.The Buzzing Gene-Editing Market Of Crispr Therapeutics40
01.03.Crispr Therapeutics: Paving The Way For The Genomic Revolution, But Perhaps Too Early To Go All-In45
23.02.CRISPR Therapeutics: Roadblock Ahead71
Seite:  Weiter >>
72 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,23,23